16-47663707-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000293.3(PHKB):​c.2309A>G​(p.Tyr770Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0438 in 1,611,382 control chromosomes in the GnomAD database, including 2,190 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.069 ( 610 hom., cov: 32)
Exomes 𝑓: 0.041 ( 1580 hom. )

Consequence

PHKB
NM_000293.3 missense

Scores

4
8
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 8.19

Publications

21 publications found
Variant links:
Genes affected
PHKB (HGNC:8927): (phosphorylase kinase regulatory subunit beta) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, encoded by this gene, which is a member of the phosphorylase b kinase regulatory subunit family. The gamma subunit also includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9B, also known as phosphorylase kinase deficiency of liver and muscle. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. Two pseudogenes have been found on chromosomes 14 and 20, respectively.[provided by RefSeq, Feb 2010]
PHKB Gene-Disease associations (from GenCC):
  • glycogen storage disease IXb
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038224757).
BP6
Variant 16-47663707-A-G is Benign according to our data. Variant chr16-47663707-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKBNM_000293.3 linkc.2309A>G p.Tyr770Cys missense_variant Exon 24 of 31 ENST00000323584.10 NP_000284.1 Q93100-1
PHKBNM_001363837.1 linkc.2309A>G p.Tyr770Cys missense_variant Exon 24 of 31 NP_001350766.1
PHKBNM_001031835.3 linkc.2288A>G p.Tyr763Cys missense_variant Exon 25 of 32 NP_001027005.1 Q93100-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKBENST00000323584.10 linkc.2309A>G p.Tyr770Cys missense_variant Exon 24 of 31 1 NM_000293.3 ENSP00000313504.5 Q93100-1

Frequencies

GnomAD3 genomes
AF:
0.0695
AC:
10578
AN:
152174
Hom.:
611
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.156
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0440
Gnomad ASJ
AF:
0.0305
Gnomad EAS
AF:
0.0138
Gnomad SAS
AF:
0.0283
Gnomad FIN
AF:
0.0182
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0411
Gnomad OTH
AF:
0.0654
GnomAD2 exomes
AF:
0.0404
AC:
10154
AN:
251204
AF XY:
0.0393
show subpopulations
Gnomad AFR exome
AF:
0.156
Gnomad AMR exome
AF:
0.0280
Gnomad ASJ exome
AF:
0.0287
Gnomad EAS exome
AF:
0.0145
Gnomad FIN exome
AF:
0.0163
Gnomad NFE exome
AF:
0.0412
Gnomad OTH exome
AF:
0.0370
GnomAD4 exome
AF:
0.0411
AC:
60021
AN:
1459090
Hom.:
1580
Cov.:
29
AF XY:
0.0405
AC XY:
29427
AN XY:
726024
show subpopulations
African (AFR)
AF:
0.157
AC:
5227
AN:
33370
American (AMR)
AF:
0.0295
AC:
1321
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0297
AC:
775
AN:
26122
East Asian (EAS)
AF:
0.00807
AC:
320
AN:
39652
South Asian (SAS)
AF:
0.0262
AC:
2258
AN:
86204
European-Finnish (FIN)
AF:
0.0156
AC:
834
AN:
53394
Middle Eastern (MID)
AF:
0.0561
AC:
323
AN:
5756
European-Non Finnish (NFE)
AF:
0.0417
AC:
46224
AN:
1109606
Other (OTH)
AF:
0.0454
AC:
2739
AN:
60280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
2546
5092
7639
10185
12731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1776
3552
5328
7104
8880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0695
AC:
10583
AN:
152292
Hom.:
610
Cov.:
32
AF XY:
0.0674
AC XY:
5019
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.155
AC:
6455
AN:
41548
American (AMR)
AF:
0.0439
AC:
671
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0305
AC:
106
AN:
3472
East Asian (EAS)
AF:
0.0137
AC:
71
AN:
5190
South Asian (SAS)
AF:
0.0277
AC:
134
AN:
4830
European-Finnish (FIN)
AF:
0.0182
AC:
193
AN:
10628
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0411
AC:
2794
AN:
68020
Other (OTH)
AF:
0.0652
AC:
138
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
481
962
1443
1924
2405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0496
Hom.:
968
Bravo
AF:
0.0759
TwinsUK
AF:
0.0388
AC:
144
ALSPAC
AF:
0.0462
AC:
178
ESP6500AA
AF:
0.152
AC:
671
ESP6500EA
AF:
0.0436
AC:
375
ExAC
AF:
0.0423
AC:
5138
Asia WGS
AF:
0.0300
AC:
105
AN:
3478
EpiCase
AF:
0.0479
EpiControl
AF:
0.0469

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glycogen storage disease IXb Benign:3
Nov 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 13, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Uncertain
0.019
T
BayesDel_noAF
Pathogenic
0.40
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.79
.;.;D;D
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.96
D;D;D;D
MetaRNN
Benign
0.0038
T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.5
.;M;M;.
PhyloP100
8.2
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-5.0
D;D;D;.
REVEL
Pathogenic
0.88
Sift
Benign
0.11
T;T;T;.
Sift4G
Benign
0.097
T;T;T;T
Polyphen
0.91
P;.;B;.
Vest4
0.81
MPC
0.56
ClinPred
0.043
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.42
gMVP
0.81
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16945474; hg19: chr16-47697618; COSMIC: COSV54520158; COSMIC: COSV54520158; API